Related references
Note: Only part of the references are listed.Presence of Severe Neuroinflammation Does Not Intensify Neurofibrillary Degeneration in Human Brain
Wolfgang J. Streit et al.
GLIA (2014)
Regulatory T cells in autoimmune neuroinflammation
Markus Kleinewietfeld et al.
IMMUNOLOGICAL REVIEWS (2014)
NLRP3 Regulates Neutrophil Functions and Contributes to Hepatic Ischemia-Reperfusion Injury Independently of Inflammasomes
Yoshiyuki Inoue et al.
JOURNAL OF IMMUNOLOGY (2014)
Knockdown of Interleukin-1 Receptor Type-1 on Endothelial Cells Attenuated Stress-Induced Neuroinflammation and Prevented Anxiety-Like Behavior
Eric S. Wohleb et al.
JOURNAL OF NEUROSCIENCE (2014)
Microglial CR3 Activation Triggers Long-Term Synaptic Depression in the Hippocampus via NADPH Oxidase
Jingfei Zhang et al.
NEURON (2014)
From development to dysfunction: Microglia and the complement cascade in CNS homeostasis
Matthew K. Zabel et al.
AGEING RESEARCH REVIEWS (2013)
Serum chemokine levels as prognostic markers in patients with early systemic sclerosis: a multicenter, prospective, observational study
Minoru Hasegawa et al.
MODERN RHEUMATOLOGY (2013)
Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia
S. G. Fillman et al.
MOLECULAR PSYCHIATRY (2013)
NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice
Michael T. Heneka et al.
NATURE (2013)
TGF-β signaling regulates neuronal Clq expression and developmental synaptic refinement
Allison R. Bialas et al.
NATURE NEUROSCIENCE (2013)
Late Anxiety-Like Behavior and Neuroinflammation in Mice Subjected to Sublethal Polymicrobial Sepsis
Allan C. Calsavara et al.
NEUROTOXICITY RESEARCH (2013)
Language Individuation and Marker Words: Shakespeare and His Maxwell's Demon
John Marsden et al.
PLOS ONE (2013)
Developmental neuroinflammation and schizophrenia
Urs Meyer
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)
A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejection
Chung-Her Jenh et al.
BMC IMMUNOLOGY (2012)
Neuroinflammation: the world is not enough
Heinz Wiendl
CURRENT OPINION IN NEUROLOGY (2012)
Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice
May H. Han et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Myelination and oxidative stress alterations in the cerebellum of the G72/G30 transgenic schizophrenia mouse model
Michaela D. Filiou et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2012)
Corticosteroids, but not NSAIDs, are associated with less Alzheimer neuropathology
Michal Schnaider Beeri et al.
NEUROBIOLOGY OF AGING (2012)
Neuroinflammation and Synaptic Loss
Jagadeesh S. Rao et al.
NEUROCHEMICAL RESEARCH (2012)
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Dorothy P. Schafer et al.
NEURON (2012)
Suppression of human CD4+T cell activation by 3,4-dimethoxycinnamonyl-anthranilic acid (tranilast) is mediated by CXCL9 and CXCL10
Anne Hertenstein et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Proteomics and Metabolomics Analysis of a Trait Anxiety Mouse Model Reveals Divergent Mitochondrial Pathways
Michaela D. Filiou et al.
BIOLOGICAL PSYCHIATRY (2011)
Role of glia in epilepsy-associated neuropathology, neuroinflammation and neurogenesis
Maira L. Foresti et al.
BRAIN RESEARCH REVIEWS (2011)
Increased numbers of immature plasma cells in peripheral blood specifically overexpress chemokine receptor CXCR3 and CXCR4 in patients with ulcerative colitis
S. Hosomi et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
Evaluation of Serum Levels of Chemokines during Interferon-β Treatment in Multiple Sclerosis Patients
Elizabeth R. Comini-Frota et al.
CNS DRUGS (2011)
Role of microglia in CNS inflammation
Manuel B. Graeber et al.
FEBS LETTERS (2011)
Expression and agonist responsiveness of CXCR3 variants in human T lymphocytes
Anna Korniejewska et al.
IMMUNOLOGY (2011)
Beta Interferon Suppresses the Development of Experimental Cerebral Malaria
Craig N. Morrell et al.
INFECTION AND IMMUNITY (2011)
Whole genome analysis of the action of interferon-beta
M.A. Kauffman et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2011)
Neuroinflammation Leads to Region-Dependent Alterations in Astrocyte Gap Junction Communication and Hemichannel Activity
Nikolay Karpuk et al.
JOURNAL OF NEUROSCIENCE (2011)
CCL5, CXCL10 and CXCL11 Chemokines in Patients with Active and Stable Relapsing-Remitting Multiple Sclerosis
Adam Szczucinski et al.
NEUROIMMUNOMODULATION (2011)
The neuroinflammatory hypothesis of delirium
Joaquim Cerejeira et al.
ACTA NEUROPATHOLOGICA (2010)
Neuroinflammation in Alzheimer's Disease and Major Depression
Nikoletta Dobos et al.
BIOLOGICAL PSYCHIATRY (2010)
Reversal of gene expression changes in the colorectal normal-adenoma pathway by NS398 selective COX2 inhibitor
O. Galamb et al.
BRITISH JOURNAL OF CANCER (2010)
Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid
J. Mellergard et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Changing Face of Microglia
Manuel B. Graeber
SCIENCE (2010)
PGC-1α, A Potential Therapeutic Target for Early Intervention in Parkinson's Disease
Bin Zheng et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Increased Mortality and Cardiovascular Morbidity Associated With Use of Nonsteroidal Anti-inflammatory Drugs in Chronic Heart Failure
Gunnar H. Gislason et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Enhancement of Chemokine Expression by Interferon Beta Therapy in Patients With Multiple Sclerosis
Sabine Cepok et al.
ARCHIVES OF NEUROLOGY (2009)
Diagnosis of Ulcerative Colitis Before Onset of Inflammation by Multivariate Modeling of Genome-wide Gene Expression Data
Jorgen Olsen et al.
INFLAMMATORY BOWEL DISEASES (2009)
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
Etienne C. Hirsch et al.
LANCET NEUROLOGY (2009)
Evaluation of Microarray Preprocessing Algorithms Based on Concordance with RT-PCR in Clinical Samples
Balazs Gyorffy et al.
PLOS ONE (2009)
Air pollution: mechanisms of neuroinflammation and CNS disease
Michelle L. Block et al.
TRENDS IN NEUROSCIENCES (2009)
Defining Neuroinflammation Lessons from MPTP- and Methamphetamine-Induced Neurotoxicity
James P. O'Callaghan et al.
DRUG ADDICTION: RESEARCH FRONTIERS AND TREATMENT ADVANCES (2008)
Duration of chronic inflammation alters gene expression in muscle from untreated girls with juvenile dermatomyositis
Yi-Wen Chen et al.
BMC IMMUNOLOGY (2008)
Molecular profiles of schizophrenia in the CNS at different stages of illness
Sujatha Narayan et al.
BRAIN RESEARCH (2008)
Alarm or curse? The pain of neuroinflammation
Carl Y. Saab et al.
BRAIN RESEARCH REVIEWS (2008)
Single nucleotide polymorphisms in human Paneth cell defensin A5 may confer susceptibility to inflammatory bowel disease in a New Zealand Caucasian population
L. R. Ferguson et al.
DIGESTIVE AND LIVER DISEASE (2008)
Noncompetitive antagonism and inverse agonism as mechanism of action of nonpeptidergic antagonists at primate and rodent CXCR3 chemokine receptors
Dennis Verzijl et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
The impact of greed on academic medicine and patient care
John V. Frangioni
NATURE BIOTECHNOLOGY (2008)
Towards a pathway definition of Parkinson's disease: a complex disorder with links to cancer, diabetes and inflammation
Linda B. Moran et al.
NEUROGENETICS (2008)
Alzheimer's disease is associated with reduced expression of energy in posterior cingulate metabolism genes neurons
Winnie S. Liang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Neuronal pentraxin II is highly upregulated in Parkinson's disease and a novel component of Lewy bodies
Linda B. Moran et al.
ACTA NEUROPATHOLOGICA (2008)
The dual inhibitor of lipoxygenase and cyclooxygenase ML3000 decreases the expression of CXCR3 ligands
C. Ospelt et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
The classical complement cascade mediates CNS synapse elimination
Beth Stevens et al.
CELL (2007)
Chemokines and chemokine receptors in neurological disease: Raise, retain, or reduce?
Carine Savarin-Vuaillat et al.
NEUROTHERAPEUTICS (2007)
CXCR3 signaling reduces the severity of experimental autoimmune encephalomyelitis by controlling the parenchymal distribution of effector and regulatory T cells in the central nervous system
Marcus Mueller et al.
JOURNAL OF IMMUNOLOGY (2007)
Benchmarking a memetic algorithm for ordering microarray data
P. Moscato et al.
BIOSYSTEMS (2007)
Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain
Winnie S. Liang et al.
PHYSIOLOGICAL GENOMICS (2007)
The microglial gene regulatory network activated by interferon-gamma
Linda B. Moran et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
CXCL11 ( interferon- inducible t- cell alpha chemoattractant) and interleukin-18 in relapsing- remitting multiple sclerosis patients treated with methylprednisolone
Adam Szczucinski et al.
EUROPEAN NEUROLOGY (2007)
Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies
Adam Szczucinski et al.
ACTA NEUROLOGICA SCANDINAVICA (2007)
Periplocoside E inhibits experimental allergic encephalomyelitis by suppressing interleukin 12-dependent CCR5 expression and interferon-γ-dependent CXCR3 expression in T lymphocytes
Yi-Na Zhu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosis
M. Krakauer et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2006)
Severe disease, unaltered leukocyte migration, and reduced IFN-γ production in CXCR3-/- mice with experimental autoimmune encephalomyelitis
LiPing Liu et al.
JOURNAL OF IMMUNOLOGY (2006)
Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson's disease
LB Moran et al.
NEUROGENETICS (2006)
Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms
YL Zhang et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2005)
Discovery of structurally diverse natural product antagonists of chemokine receptor CXCR3
John G. Ondeyka et al.
MOLECULAR DIVERSITY (2005)
Neuroglial activation and neuroinflammation in the brain of patients with autism
DL Vargas et al.
ANNALS OF NEUROLOGY (2005)
Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses
EM Blalock et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Rofecoxib - No effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study
SA Reines et al.
NEUROLOGY (2004)
CXCR1-binding chemokines in inflammatory bowel diseases: down-regulated IL-8/CXCL8 production by leukocytes in Crohn's disease and selective GCP-2/CXCL6 expression in inflamed intestinal tissue
K Gijsbers et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
What is inflammation''? Are we ready to move beyond Celsus?
A Scott et al.
BRITISH JOURNAL OF SPORTS MEDICINE (2004)
IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis
RS Klein et al.
JOURNAL OF IMMUNOLOGY (2004)
CXCR3-mediated chernotaxis of human T cells is regulated by a Gi- and phospholipase C-dependent pathway and not via activation of MEK/p44/p42 MAPK nor Akt/PI-3 kinase
MJ Smit et al.
BLOOD (2003)
Inflammatory processes in Alzheimer's disease
EG McGeer et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2003)
Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression - A randomized controlled trial
PS Aisen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Antibody-mediated blockade of the CXCR3 chemokine receptor results in diminished recruitment of T helper 1 cells into sites of inflammation
JH Xie et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
The relative activity of CXCR3 and CCR5 ligands in T lymphocyte migration: concordant and disparate activities in vitro and in vivo
MM Stanford et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
The potential of anti-inflammatory drugs for the treatment of Alzheimer's disease
PS Aisen
LANCET NEUROLOGY (2002)
Expression and modulation of IFN-γ-Inducible chemokines (IP-10, Mig, and I-TAC) in human brain endothelium and astrocytes:: Possible relevance for the immune invasion of the central nervous system and the pathogenesis of multiple sclerosis
A Salmaggi et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2002)
Interferon-β treatment alters peripheral blood monocytes chemokine production in MS patients
M Comabella et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Neuronal plasticity and cellular immunity: shared molecular mechanisms
LM Boulanger et al.
CURRENT OPINION IN NEUROBIOLOGY (2001)
Neutralization of the chemokine CXCL10 reduces inflammatory cell invasion and demyelination and improves neurological function in a viral model of multiple sclerosis
MT Liu et al.
JOURNAL OF IMMUNOLOGY (2001)
Modulation of experimental autoimmune encephalomyelitis: effect of altered peptide ligand on chemokine and chemokine receptor expression
FR Fischer et al.
JOURNAL OF NEUROIMMUNOLOGY (2000)
Expression of the interferon-γ-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions
JE Simpson et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2000)
Share Paper
